Acurx Pharmaceuticals, Inc.
ACXP • NASDAQ
Acurx Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Luci, with a market cap of $10.7M.
CEODavid Luci
Next Earnings
Upcoming earnings announcement for Acurx Pharmaceuticals, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.62
Earnings History
Past 12 earnings reports for Acurx Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Q4 2025 | -$0.73Est: -$1.00 | +27.0% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$1.23Est: -$1.54 | +20.1% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$1.89Est: -$2.06 | +8.3% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.11Est: -$0.29 | +62.1% | - | — | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.17Est: -$0.18 | +5.6% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.17Est: -$0.20 | +15.0% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.26Est: -$0.22 | -18.2% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.28Est: -$0.24 | -16.7% | - | — | 10-Q |
| Mar 18, 2024 | Q4 2023 | -$0.37Est: -$0.26 | -42.3% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.24Est: -$0.27 | +11.1% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.28Est: -$0.29 | +3.4% | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$0.25Est: -$0.29 | +13.8% | - | — | — |